Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.

Kim J, Krichevsky S, Xie L, Palumbo MC, Rodriguez-Diego S, Yum B, Brouwer L, Silver RT, Schafer AI, Ritchie EK, Yabut MM, Sosner C, Horn EM, Devereux RB, Scandura JM, Weinsaft JW.

J Am Soc Echocardiogr. 2019 Oct 3. pii: S0894-7317(19)30841-7. doi: 10.1016/j.echo.2019.07.010. [Epub ahead of print]

PMID:
31587969
2.

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with Increased blasts (<10%) or with other types of disease progression.

Geyer JT, Margolskee E, Krichevsky SA, Cattaneo D, Boiocchi L, Ronchi P, Lunghi F, Scandura JM, Ponzoni M, Hasserjian RP, Gianelli U, Iurlo A, Orazi A.

Haematologica. 2019 Sep 19. pii: haematol.2019.230193. doi: 10.3324/haematol.2019.230193. [Epub ahead of print]

3.

Lessons Learned in the Development of a Computable Phenotype for Response in Myeloproliferative Neoplasms.

Sholle E, Krichevsky S, Scandura J, Sosner C, Campion TR Jr.

IEEE Int Conf Healthc Inform. 2018 Jun;2018:328-331. doi: 10.1109/ICHI.2018.00045. Epub 2018 Jul 26.

4.

Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values.

Silver RT, Krichevsky S.

Haematologica. 2019 Nov;104(11):2200-2205. doi: 10.3324/haematol.2018.213108. Epub 2019 Apr 4.

5.

Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera.

Silver RT, Krichevsky S, Gjoni S, Cross NCP.

Leuk Lymphoma. 2017 Nov;58(11):2768-2769. doi: 10.1080/10428194.2017.1300892. Epub 2017 Mar 20. No abstract available.

PMID:
28317411
6.

The JAK2V617F mutation in normal individuals takes place in differentiating cells.

Krichevsky S, Prus E, Perlman R, Fibach E, Ben-Yehuda D.

Blood Cells Mol Dis. 2017 Mar;63:45-51. doi: 10.1016/j.bcmd.2017.01.001. Epub 2017 Jan 7.

PMID:
28126623
7.

Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.

Rottenstreich A, Kleinstern G, Krichevsky S, Varon D, Lavie D, Kalish Y.

Eur J Intern Med. 2017 Jun;41:49-54. doi: 10.1016/j.ejim.2016.11.011. Epub 2016 Dec 2.

PMID:
27919526
8.

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients.

Margolskee E, Krichevsky S, Orazi A, Silver RT.

Haematologica. 2017 Mar;102(3):e97-e99. doi: 10.3324/haematol.2016.153973. Epub 2016 Nov 3. No abstract available.

9.

The prognostic value of bone marrow involvement at the molecular level in aggressive lymphoma.

Goldschmidt N, Darawshy F, Kleinstern G, Slyusarevsky E, Pogrebijski G, Krichevsky S, Ben-Yehuda D, Gatt ME.

Leuk Lymphoma. 2017 Jan;58(1):45-52. Epub 2016 Oct 18.

PMID:
27756163
10.

Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.

Ganzel C, Pogrebijsky G, Krichevsky S, Neuman T, Yehuda DB.

Exp Hematol. 2012 Sep;40(9):698-704.e2. doi: 10.1016/j.exphem.2012.05.009. Epub 2012 Jun 1.

PMID:
22659385
11.

Fat mass loss predicts gain in physical function with intentional weight loss in older adults.

Beavers KM, Miller ME, Rejeski WJ, Nicklas BJ, Kritchevsky SB.

J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):80-6. doi: 10.1093/gerona/gls092. Epub 2012 Apr 13. Erratum in: J Gerontol A Biol Sci Med Sci. 2014 Oct;69(10):1306. Krichevsky, Stephen B [Corrected to Kritchevsky, Stephen B].

12.

Janus Kinase V617F mutation in cigarette smokers.

Weinberg I, Borohovitz A, Krichevsky S, Perlman R, Ben-Yehuda A, Ben-Yehuda D.

Am J Hematol. 2012 Jan;87(1):5-8. doi: 10.1002/ajh.22180. Epub 2011 Sep 26.

13.

Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.

Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D.

Oral Dis. 2009 Apr;15(3):206-13. doi: 10.1111/j.1601-0825.2008.01510.x. Epub 2009 Jan 16.

PMID:
19207881
14.

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.

Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, Gural A, Shafran-Tikva S, Ben-Neriah S, Ben-Yehuda D.

Leukemia. 2005 Nov;19(11):1919-28.

PMID:
16167058
15.

Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage.

Goldberg Z, Levav Y, Krichevsky S, Fibach E, Haupt Y.

Cell Cycle. 2004 Sep;3(9):1188-95. Epub 2004 Sep 2.

PMID:
15467443
16.

Age related microsatellite instability in T cells from healthy individuals.

Krichevsky S, Pawelec G, Gural A, Effros RB, Globerson A, Yehuda DB, Yehuda AB.

Exp Gerontol. 2004 Apr;39(4):507-15.

PMID:
15050284
17.

Expression of EBV encoded nuclear small non-polyadenylated RNA (EBER) molecules in 32 cases of childhood Burkitt's lymphoma from Israel.

Peylan-Ramu N, Diment J, Krichevsky S, Ben-Yehuda D, Bhatia K, Magrath IT.

Leuk Lymphoma. 2001 Jan;40(3-4):405-11.

PMID:
11426563
18.

Ageing and the mismatch repair system.

Ben Yehuda A, Globerson A, Krichevsky S, Bar On H, Kidron M, Friedlander Y, Friedman G, Ben Yehuda D.

Mech Ageing Dev. 2000 Dec 20;121(1-3):173-9. Review.

PMID:
11164471
19.

ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.

Asimakopoulos FA, Shteper PJ, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y, Ben-Yehuda D.

Blood. 1999 Oct 1;94(7):2452-60.

PMID:
10498618
20.

Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms.

Gafanovich A, Ramu N, Krichevsky S, Pe'er J, Amir G, Ben-Yehuda D.

Cancer. 1999 Jan 15;85(2):504-10.

PMID:
10023722
21.

Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia.

Ben-Yehuda D, Krichevsky S, Rachmilewitz EA, Avraham A, Palumbo GA, Frassoni F, Sahar D, Rosenbaum H, Paltiel O, Zion M, Ben-Neriah Y.

Blood. 1997 Dec 15;90(12):4918-23.

PMID:
9389709
22.

Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.

Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA.

Blood. 1996 Dec 1;88(11):4296-303.

PMID:
8943866
23.

Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.

Abeliovich D, Yehuda O, Krichevsky S, Nagler A, Ben-Neriah S, Werner M, Ludkovsky O, Ben-Yehuda D.

Cancer Genet Cytogenet. 1995 Jun;81(2):115-7.

PMID:
7621406

Supplemental Content

Loading ...
Support Center